PharmaShots | Incisive News in 3 Shots

Subscribe Now

Evrysdi

Roche and PTC's Evrysdi (risdiplam) Receive the EC's Approval as First and Only at Home Treatment For Spinal Muscular Atrophy

Roche and PTC's Evrysdi (risdiplam) Receive the EC's Approval as First and Only at Home Treatment For Spinal Muscular Atrophy

March 30, 2021

Roche Reports Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA

Roche Reports Two-Year Data for Evrysdi (risdiplam) in Infants with Type 1 SMA

September 28, 2020

PTC Reports the EMA's Acceptance of MAA for Evrysdi (risdiplam) to Treat SMA

PTC Reports the EMA's Acceptance of MAA for Evrysdi (risdiplam) to Treat SMA

August 18, 2020

Roche's Evrysdi (risdiplam) Receives the US FDA's Approval for SMA in Adults and Children

Roche's Evrysdi (risdiplam) Receives the US FDA's Approval for SMA in Adults and Children

August 10, 2020

Contact Us

First Floor, B-66, Sector 63 Noida, Uttar Pradesh, INDIA - 201301
+91-120 428 0707
connect@pharmashots.com
Newsletter

Our Information

Follow Us